Petros Pharmaceuticals In...

NASDAQ: PTPI · Real-Time Price · USD
0.03
-0.00 (-10.18%)
At close: Jun 09, 2025, 3:15 PM

Petros Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.71M 13.34M 9.43M 23.85M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a 4.18M 5.11M 11.03M
Receivables
416.08K 2.23M 2.11M 2.46M
Inventory
1.35M 1.61M 1.82M 519.65K
Other Current Assets
1.66M 816.21K 802.21K 1.53M
Total Current Assets
7.29M 20.39M 14.67M 30.54M
Property-Plant & Equipment
136.68K 255.22K 397.65K 524.95K
Goodwill & Intangibles
3.2M 8.97M 12.24M 25.29M
Total Long-Term Assets
3.34M 13.41M 17.75M 36.85M
Total Assets
10.64M 33.8M 32.42M 67.39M
Account Payables
2.33M 1.71M 1.81M 4.56M
Deferred Revenue
1.91M 2.05M n/a -125.58K
Short-Term Debt
7.25M 1.16M 1.09M n/a
Other Current Liabilities
8.39M 1.11M 2.71M 22.93M
Total Current Liabilities
18.03M 10.77M 7.07M 30.98M
Long-Term Debt
n/a 6.86M 8.39M n/a
Other Long-Term Liabilities
75.15M 3.55M 1.00 460K
Total Long-Term Liabilities
75.22M 10.55M 8.65M 865.02K
Total Liabilities
18.1M 21.32M 15.72M 31.85M
Total Debt
7.39M 8.28M 9.88M 405.02K
Common Stock
1.05K 298.00 208.00 2.07K
Retained Earnings
-113.21M -98.89M -90.73M -70.69M
Comprehensive Income
n/a n/a n/a 0.00
Shareholders Equity
-7.47M 12.48M 16.7M 35.54M
Total Investments
3.71B n/a n/a n/a